Montidine 25 mg (Levomepromazine)

Adult dose

Adults: Take 25 mg of levosulpiride orally 3 times daily before meals.

This medication should not be used by women who are pregnant or may become pregnant, and by lactating women. It should also not be administered to patients who have gastrointestinal bleeding, mechanical obstruction, or are at risk of gastrointestinal perforation. It is contraindicated in patients with specific tumors such as pheochromocytoma, as it may cause hypertension. Patients with a history of allergic reactions to this medication or who cannot tolerate it should also not receive it. Care should be taken in patients with liver disease, bipolar disorder, and malignant breast disease. Additionally, this medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Caution is required when used in hypertensive patients, children, and the elderly, particularly in the case of overdose in children. Abnormal endocrine symptoms such as amenorrhea, galactorrhea, and gynecomastia may occur, and if any unusual symptoms appear, the medication should be discontinued immediately. Extrapyramidal symptoms such as tremors or tongue twisting and restlessness may rarely appear, and treatment should be stopped if such symptoms occur. Long-term use may lead to involuntary movements around the mouth, and these may persist even after stopping the medication, requiring careful attention. Gastrointestinal symptoms such as dry mouth, heartburn, nausea, vomiting, diarrhea, and constipation may occur. Cardiac-related issues such as hypertension or arrhythmias may also require monitoring. Serious adverse effects such as Neuroleptic Malignant Syndrome may occur, requiring immediate discontinuation of the medication and medical treatment if symptoms such as high fever, muscle rigidity, or altered consciousness present. Rarely, skin rash or edema may occur, along with flushing, fatigue, insomnia, drowsiness, dizziness, and unsteadiness. It is advisable to avoid activities requiring attention, such as driving or operating machinery, while taking this medication. There may be interactions with other medications, so caution should be exercised particularly when used in conjunction with anticholinergics, analgesics, digitalis preparations, and psychiatric medications. When combined with medications that carry a risk of cardiac arrhythmias, cardiac conditions should be closely monitored, and it should not be used with medications that cause electrolyte disturbances. Pregnant or lactating women should avoid taking this medication due to uncertainty about its effects on the fetus or newborn. The elderly should be cautious as reduced renal function may prolong the drug's presence in the body, requiring careful adjustment of dosage and intervals. This medication can suppress vomiting symptoms, so it should be used cautiously after accurately identifying the cause of vomiting, as there are reports of potential effects on reproductive function in animal studies. Furthermore, long-term high-dose administration has been associated with reports of tumor development in the pituitary gland or breast tissue, so vigilance is necessary with prolonged use.

• Amenorrhea
• Hyperprolactinemia
• Gynecomastia
• Tremors
• Tongue twisting
• Anxiety
• Involuntary movements around the mouth
• Thirst
• Heartburn
• Nausea

This medication should be stored in a tightly closed container to protect it from air and light. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the drug's effectiveness and prevent degradation.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle